Exploring oxylipins in processed foods: Understanding mechanisms, analytical perspectives, and enhancing quality with lipidomics.

Oxylipins are active lipid compounds formed through the oxidation of unsaturated fatty acids. These compounds have drawn considerable attention due to the potential impact on human health and processed food quality. Therefore, this study aimed to deepen current understanding and assess recent analytical advancements regarding the physiological roles of oxylipins in processed food products using lipidomics. The mechanisms behind oxylipins production in processed foods were extensively investigated, underscoring potential associations with chronic diseases. This indicates the need for innovative strategies to mitigate harmful oxylipins levels to enhance the safety and shelf life of processed food products. The results showed that mitigation methods, including the use of antioxidants and optimization of processing parameters, reduced oxylipins levels. The integration of lipidomics with food safety and quality control processes is evident in cutting-edge methods such as nuclear magnetic resonance and mass spectrometry for compliance and real-time evaluation. Aside from envisioning the future trajectory of food science and industry through prospective studies on oxylipins and processed foods, the results also provide the basis for future investigations, innovation, and advancements in the dynamic field of food science and technology.

Absorption and Safety of Topically Applied Timolol for Treatment of Chronic Cutaneous Wounds.

Objective: There are no safety or absorption studies to guide topical timolol therapy for treatment of chronic wounds. This study was undertaken to address this gap. Approach: A prospective, observational, cross-sectional comparative study of timolol plasma levels in patients after topical administration to a chronic wound, compared with levels in patients after timolol ocular administration for the indication of glaucoma. Results: There was no statistically significant difference in the average plasma level of timolol in wound as compared with glaucoma patients. No bradycardia or wheezing was observed after administration. Innovation: We determined the single time point concentration of timolol in plasma 1 h after application of timolol 0.5% gel-forming solution to debrided chronic wounds, providing insight as to the safety of this emerging off-label treatment. Conclusion: The topical application of timolol for chronic wounds shares the same safety profile as the widely used application of ocular administration for glaucoma.

Development of a novel ion-pairing UPLC method with cation-exchange solid-phase extraction for determination of free timolol in human plasma.

A novel UPLC-UV method was developed for analysis of timolol in human plasma using a simple, fast, and cost effective ion-exchange SPE procedure, followed by separation on a C18 UPLC column with a mobile phase consisting of acetonitrile, phosphate buffer, and sodium 1-octane sulfonate as an ion pairing agent. The method was fully validated according to US-FDA guidelines, and was found to be sufficiently accurate and precise for analysis of timolol in human plasma for clinical pharmacokinetic studies. The application of ion-exchange SPE cartridges for purification of timolol in plasma produced excellent percent recoveries and good sample clean-up, while the ion-pairing separation described here allowed quantitation of timolol without interference from endogenous sample components. The method lower limit of detection was 1.7 ng/mL and the lower limit of quantitation was 5.0 ng/mL, allowing for analysis of therapeutic concentrations of timolol in plasma.

Determination of levoglucosan in atmospheric aerosols using high performance liquid chromatography with aerosol charge detection.

A sensitive method for analysis of levoglucosan (1,6-anhydro-beta,d-glucopyranose) and other monosaccharide anhydrides, compounds present in biomass combustion smoke, was investigated employing high-performance liquid chromatography (HPLC) with recently developed aerosol charge detection. Aerosol charge detection involves the conversion of the column effluent to an aerosol, which is charged to produce a current. Use of a cation-exchange column and a pure water eluent was found to separate levoglucosan and mannosan from other aerosol components with a detection limit of about 90 ng mL(-1) for levoglucosan or 5 ng injected. This method was demonstrated by successful analysis of aerosol filter samples from three locations.

Development and testing of a detection method for liquid chromatography based on aerosol charging.

Aerosol-based detection methods for HPLC in which HPLC effluent is converted to an aerosol and detected optically have been employed in the past. This paper describes a new aerosol-based detection method for HPLC, which we name aerosol charge detection. This detection method also involves generation of an aerosol but with aerosol detection by charging aerosol particles and measuring the current from the charged particle flux. A commercial electrical aerosol size analyzer was used for the aerosol detection. The constructed detector was tested using flow injection analysis with water as the mobile phase, and the signal response was found to be linear for sodium sulfate over the concentration ranges of 0.2-100 microg mL(-1) using one of the nebulizers. Minimum mass and concentration detection limits using the more efficient nebulizer were estimated to be 0.2 ng and 10 ng mL(-1), respectively. Behavior for most of the other compounds tested was similar with some differences in sensitivity. Testing the detector using reversed phase HPLC for glucose gave a range of linear response and detection limits that were similar to the flow injection analysis studies. Under most HPLC conditions, the noise will primarily be a function of solvent impurities; however, the electrical aerosol size analyzer allows the removal of small charged particles to improve the signal-to-noise ratio.